These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1585930)

  • 21. In vitro comparison of peracetic acid and bleach cleaning of polysulfone hemodialysis membranes.
    Shao J; Wolff S; Zydney AL
    Artif Organs; 2007 Jun; 31(6):452-60. PubMed ID: 17537057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
    Teehan GS; Guo D; Perianayagam MC; Balakrishnan VS; Pereira BJ; Jaber BL
    Blood Purif; 2004; 22(4):329-37. PubMed ID: 15240988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures.
    Mayer G; Thum J; Woloszczuk W; Graf H
    Am J Nephrol; 1988; 8(4):280-4. PubMed ID: 3055992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: the beta2-microglobulin/albumin relationship.
    Ahrenholz PG; Winkler RE; Michelsen A; Lang DA; Bowry SK
    Clin Nephrol; 2004 Jul; 62(1):21-8. PubMed ID: 15267009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation and comparison of polysulfone TS-UL and PMMA NF-U dialyzers versus expanded hemodialysis and postdilution hemodiafiltration.
    Maduell F; Broseta JJ; Rodríguez-Espinosa D; Hermida-Lama E; Rodas LM; Gómez M; Arias-Guillén M; Fontseré N; Vera M; Rico N
    Artif Organs; 2021 Sep; 45(9):E317-E323. PubMed ID: 33908062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dialyzer-dependent changes in solute and water permeability with bleach reprocessing.
    Scott MK; Mueller BA; Sowinski KM; Clark WR
    Am J Kidney Dis; 1999 Jan; 33(1):87-96. PubMed ID: 9915272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers.
    Sundaram S; Barrett TW; Meyer KB; Perrella C; Neto MC; King AJ; Pereira BJ
    J Am Soc Nephrol; 1996 Oct; 7(10):2183-91. PubMed ID: 8915979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of bleach reprocessing upon the clearance characteristics and surface charge of polysulfone hemodialyzers.
    Shao J; Zydney AL
    ASAIO J; 2004; 50(3):246-52. PubMed ID: 15171477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of dialyzer reuse on survival of patients treated with hemodialysis.
    Feldman HI; Kinosian M; Bilker WB; Simmons C; Holmes JH; Pauly MV; Escarce JJ
    JAMA; 1996 Aug; 276(8):620-5. PubMed ID: 8773634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficiency of post-dilution hemodiafiltration with a high-flux α-polysulfone dialyzer.
    Pedrini LA; Gmerek A; Wagner J
    Int J Artif Organs; 2011 May; 34(5):397-404. PubMed ID: 21574157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysate protein losses with bleach processed polysulphone dialyzers.
    Kaplan AA; Halley SE; Lapkin RA; Graeber CW
    Kidney Int; 1995 Feb; 47(2):573-8. PubMed ID: 7723243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
    Kadiri S; Kehinde Z; Arije A; Salako BL
    Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphate clearance for bleach reprocessed polysulfone hemodialyzers: effects of electrostatic interactions.
    Shaffer JF; Zydney AL
    ASAIO J; 2005; 51(6):748-53. PubMed ID: 16340362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled open-label trial of vitamin E-bonded polysulfone dialyzer and erythropoiesis-stimulating agent response.
    Sanaka T; Mochizuki T; Kinugasa E; Kusano E; Ohwada S; Kuno T; Kojima K; Kobayashi S; Satoh M; Shimada N; Nakao K; Nakazawa R; Nishimura H; Noiri E; Shigematsu T; Tomo T; Maeda T;
    Clin J Am Soc Nephrol; 2013 Jun; 8(6):969-78. PubMed ID: 23599410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro performance of hemodialysis membranes after repeated processing.
    Johnson A; Mishkin GJ; Lew SQ; Mishkin M; Abramson F; Lecchi P
    Am J Kidney Dis; 2003 Sep; 42(3):561-6. PubMed ID: 12955685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
    McCarthy JT; Jenson BM; Squillace DP; Williams AW
    Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-flux helixone dialyzers].
    Sobaszek-Pitas M; Kopeć J; Krzanowski M; Sułowicz W
    Przegl Lek; 2014; 71(7):384-8. PubMed ID: 25338334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficiency of high-flow dialyzers in removal of beta-2-microglobulin].
    Leto E; Bilal F; Osmic I
    Med Arh; 2001; 55(4):225-6. PubMed ID: 11769451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.